Barbiturates are usually administered intravenously in the neonatal intensive care unit (NICU) to ensure precise dosing. Continuous monitoring of vital signs, including respiratory rate, heart rate, and blood pressure, is essential. Blood levels of the drug may also be monitored to avoid toxicity. Clinical assessment of the neonate’s neurological status is critical to adjust dosing appropriately.